ITUS Corporation is developing a platform called Cchek™, a series of inexpensive non-invasive blood tests for the early detection of cancer.
ITUS is developing chimeric antigen receptor T-cell (CAR T) therapies which genetically engineer a patient's own immune cells to fight cancer.
Strong Leadership Backed by Success
Our management team has had many successes, especially in connection with starting, building and investing in technology related companies.
Sign up for email Updates
Be The First to Receive Breaking NewsSign Up Now